Im Universitätsklinikum Magdeburg A.ö.R. sind rund 4.100 Mitarbeiter in über 20 Instituten und 25 Kliniken tätig. Es ist mit etwa 1.100 Planbetten das größte Krankenhaus Magdeburgs und im nördlichen Sachsen-Anhalt. Der derzeitige Ärztliche Leiter des Universitätsklinikums ist Hans-Jochen Heinze.

During the past decade, Universitätsklinikum Magdeburg conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 36 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 22 clinical trials were completed. i.e. 81.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Magdeburg" #1 sponsor was "University of Ulm" with 11 trials, followed by "German CLL Study Group" with 9 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored and "AGO Study Group" with 5 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 96 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Magdeburg" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Cancer Trials Ireland" with 2 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Magdeburg" are "Lymphoma" (8 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Acute Myeloid Leukemia" (6 trials), "Ovarian Cancer" (6 trials) and "Acute Myeloid Leukemia (AML)" (4 trials). Many other conditions were trialed in "Universitätsklinikum Magdeburg" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Magdeburg" are "Drug" (106 trials), "Biological" (24 trials), "Device" (21 trials), "Radiation" (17 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "cyclophosphamide" (12 trials), "radiation therapy" (11 trials), "doxorubicin hydrochloride" (9 trials) and "filgrastim" (9 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Magdeburg" are 139 trials for "All" genders, 11 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Magdeburg". undefined are not yet recruiting, 25 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 84 completed trials in Universitätsklinikum Magdeburg, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Magdeburg, 7 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 16 trials that are defined as “Not Applicable".

Universitätsklinikum Magdeburg has several departments that took part in Clinical trials: "Department of Urology University Hospital Otto-von-Guericke-University Magdeburg" - 3 trials, "Otto von Guericke University Magdeburg, Department of Pediatrics" - 2 trials